Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Cellivery Therapeutics Inc patents

Recent patent applications related to Cellivery Therapeutics Inc. Cellivery Therapeutics Inc is listed as an Agent/Assignee. Note: Cellivery Therapeutics Inc may have other listings under different names/spellings. We're not affiliated with Cellivery Therapeutics Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Cellivery Therapeutics Inc-related inventors




Date Cellivery Therapeutics Inc patents (updated weekly) - BOOKMARK this page
07/13/17Cell-permeable (icp)-socs3 recombinant protein and uses thereof
07/06/17Cell-permeable (icp)-socs3 recombinant protein and uses thereof
05/18/17Cell-permeable (icp)-socs3 recombinant protein and uses thereof
02/02/17Development of improved cell-permeable (icp) parkin recombinant protein as a protein-based anti-neurodegenerative agent for the treatment of parkinson's disease-associated phenotypes by utilizing bbb-penetrating protein delivery system mitt, enabled by advanced macromolecule transduction domain (amtd)
03/24/16Development of protein-based biotherapeutics that penetrate cell-membrane and induce anti-cancer effect - cell-permeable trefoil factor 1 (cp-tff1) in gastrointestinal track (git) cancer, polynucleotides encoding the same, and anti-cancer compositions comprising the same
03/10/16Development of protein-based biotherapeutics that penetrate cell-membrane and induce anti-cancer effect- cell-permeable glutathione peroxidase7 (cp-gpx7) in gastrointestinal track (git), polynucleotides encoding the same, and anti-cancer compositions comprising the same
03/03/16Development of protein-based biotherapeutics that penetrates cell-membrane and induces anti-hepatocellular carcinoma effect - improved cell-permeable suppressor of cytokine signaling (icp-socs3) proteins, polynucleotides encoding the same, and anti-hepatocellular carcinoma compositions comprising the same
03/03/16Development of protein-based biotherapeutics that penetrates cell-membrane and induces anti-lung cancer effect - improved cell-permeable suppressor of cytokine signaling (icp-socs3) proteins, polynucleotides encoding the same, and anti-lung cancer compositions comprising the same
03/03/16Development of protein-based biotherapeutics that penetrates cell-membrane and induces anti-pancreatic cancer effect - improved cell-permeable suppressor of cytokine signaling (icp-socs3) proteins, polynucleotides encoding the same, and anti-pancreatic cancer compositions comprising the same
03/03/16Development of protein-based biotherapeutics that penetrates cell-membrane and induces anti-angiogenic effect - improved cell-permeable suppressor of cytokine signaling (icp-socs3) proteins, polynucleotides encoding the same, and anti-angiogenic compositions comprising the same
03/03/16Development of a protein-based biotherapeutic agent that penetrates cell-membrane and induces anti-tumor effect in solid tumors - improved cell-permeable suppressor of cytokine signaling (icp-socs3) proteins, polynucleotides encoding the same, and anti-tumor compositions comprising the same
03/03/16Development of protein-based biotherapeutics that induced osteogenesis for bone healing therapy: cell-permeable bmp2 and bmp7 recombinant proteins (cp-bmp2 & cp-bmp7), polynucleotides encoding the same and pro-osteogenic compositions comprising the same







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Cellivery Therapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Cellivery Therapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';